Share Name Share Symbol Market Type Share ISIN Share Description
Silence Ther. LSE:SLN London Ordinary Share GB00B9GTXM62 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.75p -0.64% 115.75p 112.00p 119.50p 116.00p 114.50p 114.50p 10,125 16:35:18
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -3.8 -2.3 - 153.16

Silence Therapeutics Share Discussion Threads

Showing 50401 to 50424 of 50425 messages
Chat Pages: 2017  2016  2015  2014  2013  2012  2011  2010  2009  2008  2007  2006  Older
DateSubjectAuthorDiscuss
12/10/2018
18:32
erratum in deed!
waterloo01
12/10/2018
17:23
Now that's an interesting mistake. I had a moment's panic when I read about the placing! But CAKE and SLN appear to have different brokers, so I'm not sure it can be taken as an indication that SLN are expecting to put out an RNS imminently, on raising funds, settling litigation or anything else. But how do you put out a CAKE RNS under the SLN name?
1gw
12/10/2018
08:16
Cant imagine why anybody would sell up at the moment, the news all appears very positive ,must make sense to hang around for a couple of months and let the story play out .
partner
11/10/2018
12:48
Yes, not the best day to announce what is undoubtedly good news. The news yesterday re seeking injunctive relief suggests that ALNY are either unwilling or reluctant to settle, though.
callumross
11/10/2018
12:30
I expect them to settle before the hearing. Could be any day, but the ex CEO purchase seems a good indicator it might be sooner rather than later. After all they have enough cash! Added a few this week and good to see the price hold firm in this correction.
waterloo01
11/10/2018
10:32
Very encouraging preliminary result, putting more pressure on ALNY in addition to the injunctive action against Patisiran announced yesterday. If their first commercial product cannot be sold in the EU pending clarification on the SLN action, now that really would pressurize them to settle.
callumross
05/10/2018
17:37
Interesting to compare the shares on loan position with the share price chart. According to Euroclear, SoL monthly average this year is as follows: 1.4m Jan (average shares on loan) 1.4m Feb 2.6m Mar 4.3m Apr 4.2m May 4.2m Jun 4.1m Jul 3.9m Aug 2.3m Sep So it looks like a significant increase in short positions in March and April (assuming the SoL correlates to short positions) may have helped to knock the shareprice off its 200p perch. hTtps://my.euroclear.com/apps/en/monthly-stock-loan-data.html#month=eq:9&year=eq:2018&limit=0&search=1&order=asc:abbreviation
1gw
05/10/2018
14:27
That's a big vote of confidence from Ali, I think. Great to see him putting his money in after leaving the CEO position. So I've bought another chunk there. It was right to follow him into ARWR, so I'm prepared to go with him on this as well.
1gw
04/10/2018
17:59
Will listen tonight. Makes you wonder why SLN are so ridiculously underperforming the sector - management changes, legal battles? In the next 3 months we have the Quark phase 3 results, the filing of the new trial drug and the legal action re Patisiran on 10th December so plenty newsflow.
callumross
04/10/2018
17:14
"Billion plus"? Did anyone else listen to the CEO's presentation at Cantor Fitzgerald? hTtps://www.silence-therapeutics.com/news-media/events/ Right at the end there's a bullish comment something like: "So that's why companies like Arrowhead, like Dicerna, are ramping up to the billion plus, and I think we'll not be far behind...simply because people see value, they see safety etc and they see a validated class in the pharmacopeia."
1gw
04/10/2018
16:16
Whoops. On the plus side, along with recent Alnylam updates the area seems to have some renewed interest.
waterloo01
04/10/2018
16:11
"J&J, Arrowhead in gene-silencing drug deal worth up to $3.7 billion" "J&J will make a $75 million equity investment in Arrowhead at $23 per share, a premium of about 24 percent to the stock's Wednesday close. Arrowhead will also get $175 million upfront, the company said in a statement." hTtps://uk.finance.yahoo.com/news/j-j-arrowhead-gene-silencing-115253968.html
1gw
25/9/2018
13:01
Might get my next tranche at 110p by the look of things
volsung
24/9/2018
11:01
Silence Therapeutics will be presenting to investors at the upcoming Proactive One2One Forum on 4th October in Mayfair,London from 6pm. Details here: https://tinyurl.com/yb3j5c7z
aim_trader
11/9/2018
16:09
So much for that then
viku111
10/9/2018
20:49
Fingers crossed for tomorrow then.
1gw
06/9/2018
22:02
It bugged me when he said that the stake in arrowhead didn't mean that SLN was to become an investment vehicle - I was thinking why not? All the talent was in place for just that. My guess is that was seed of boardroom dissent.
djnzloop
06/9/2018
19:48
Well in hindsight it does make me wonder if a board-level disagreement over what to do with the arwr stake might have led eventually to Ali's departure.
1gw
06/9/2018
19:27
I think it was about 10 million invested .. times 10 at today's rate.Enough to make a CEO run for the hills
djnzloop
06/9/2018
16:52
ARWR up about 40% at the moment and crossed $20 earlier. That would have been well over a 10-bagger for SLN if they'd held wouldn't it? Maybe we can hope to catch some of the upbeat sentiment. hTtps://www.nasdaq.com/article/arrowhead-pharmaceuticals-inc-arwr-has-risen-to-a-new-high-on-study-data-20180906-00725 hTtps://uk.finance.yahoo.com/news/arrowhead-presents-aro-hbv-clinical-113000104.html
1gw
06/9/2018
14:56
Perhaps some buying in anticipation of a positive update on the litigation with the half-year results on Tuesday? Conference call for analysts scheduled for that day.
1gw
06/9/2018
11:28
Some nice crosses appearing on the charts. Bodes well
volsung
30/8/2018
19:54
Spend 20% of their Cash on SLN and i'd be happy enough.
frndlyfire
30/8/2018
16:11
Settling the patent dispute.
waterloo01
Chat Pages: 2017  2016  2015  2014  2013  2012  2011  2010  2009  2008  2007  2006  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20181022 20:39:09